{
    "Trade/Device Name(s)": [
        "Xpert\u00ae Flu",
        "Cepheid Xpert\u00ae Flu Assay"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K123191",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120911"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OQW",
        "001"
    ],
    "Summary Letter Date": "October 9, 2012",
    "Summary Letter Received Date": "October 11, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 866.3332"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Reagents for detection of specific novel influenza A viruses"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A",
        "Influenza B",
        "2009 H1N1 influenza viral RNA"
    ],
    "Specimen Type(s)": [
        "Nasal aspirates/washes (NA/W)",
        "Nasopharyngeal (NP) swabs"
    ],
    "Specimen Container(s)": [
        "Universal Transport Medium (UTM) tube (3 mL)"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert Instrument Systems",
        "GeneXpert Dx System",
        "GeneXpert Infinity-48 System",
        "GeneXpert Infinity-80 System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex real-time reverse transcription PCR (rRT-PCR)",
        "Real-time PCR",
        "RT-PCR",
        "Sample purification",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex nucleic acid detection",
        "Qualitative analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert Flu multiplex real-time RT-PCR assay for qualitative detection of influenza A, B, and 2009 H1N1 viral RNA in respiratory specimens",
    "Indications for Use Summary": "Qualitative detection and differentiation of influenza A, influenza B, and 2009 H1N1 influenza viral RNA from nasal aspirates/washes and nasopharyngeal swab specimens of patients with signs and symptoms of respiratory infection, intended as an aid in the diagnosis of influenza",
    "fda_folder": "Microbiology"
}